Company intelligence / Profile preview

Beijing Da-an Bio-technology

Ownership: Private
Development stage: Other

Overview

Dabeinong Biotechnology has developed proprietary genetically engineered crop varieties such as herbicide-resistant soybeans. Their transgenic varieties have received regulatory approvals in multiple countries including Argentina and China, with strong performance in multi-point trials and pilot plantings organized by the Ministry of Agriculture and Rural Affairs of China. The company holds over 230 granted patents domestically and internationally.

Modalities: Genetically modified cropsTransgenic technology
Industry: Agriculture & AgTech

Partnerships

Over 200 seed companies and breeding institutions globally for R&D collaboration/commercialization.

Beyond the preview

Go deeper on Beijing Da-an Bio-technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Da-an Bio-technology.

Explore the full profile